Sarah Condella - Apr 30, 2021 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
SVP, Human Resources
Signature
/s/ Sarah Condella by Mark R. Busch, attorney-in-fact
Stock symbol
EXAS
Transactions as of
Apr 30, 2021
Transactions value $
-$632,765
Form type
4
Date filed
6/11/2021, 07:11 PM
Next filing
Feb 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Award $21.2K +328 +0.44% $64.74 74.4K Apr 30, 2021 Direct F1
transaction EXAS Common Stock Sale -$420K -3.5K -4.71% $120.00 70.9K Jun 10, 2021 Direct F2
transaction EXAS Common Stock Options Exercise $9.81K +1.95K +2.75% $5.03* 72.8K Jun 10, 2021 Direct
transaction EXAS Common Stock Sale -$234K -1.95K -2.68% $120.00 70.9K Jun 10, 2021 Direct
holding EXAS Common Stock 4.92K Apr 30, 2021 Held in 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXAS Stock Option (right to buy) Options Exercise -$9.81K -1.95K -15.18% $5.03* 10.9K Jun 10, 2021 Common Stock 1.95K $5.03 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock purchased through Employee Stock Purchase Plan.
F2 The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan.
F3 Grant has a graded vesting schedule. Date Exercisable will vary for each vesting tranche.